Sucrose at Triage for Acute Gastroenteritis Episode in Children
NCT05378776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2025-05-18
Summary
Background: Acute viral gastroenteritis is a very common pediatric medical condition that results in a large number of emergency department (ED) visits. Fasting-induced ketosis has been suggested to contribute to nausea and vomiting in children with VGE. To date, there is no data on the impact of oral sucrose intake during oral rehydration.
Objective: The aim of this study is to assess the impact of providing a sucrose solution at triage to young children with suspected acute viral gastroenteritis on the amount of rehydration solution intake in the first 2 hours. We will also assess the proportion of discharge after initial medical evaluation, the proportion of oral rehydration failure, the number of vomiting episodes per patient, ondansetron administration, the time between the intervention and ED discharge, the time between the first medical contact and ED discharge and return visits within 48 hours.
Methods:
This study will be a double-blind randomized controlled trial. Recruitment will take place in a tertiary pediatric ED. Participants will be all children who present to the ED with suspected acute acute viral gastroenteritis with at least three vomiting in the previous 24 hours. The intervention will consist in giving 1.5 ml/kg of a sucrose solution composed of diluted juice with added table sugar (3.5g of sucrose/10 ml) compared with 1.5 ml/kg of diluted juice (0.5g of sucrose/10 mL, standard of care in our ED). Following that, all participants will be rehydrated with 15 mL of diluted juice every 15 minutes or more if tolerated. The primary outcome will be the amount of rehydration solution (ml) absorbed in the first two hours following intervention. Secondary outcomes will include disposition after initial medical evaluation, oral rehydration failure, the number of vomiting, ondansetron administration, the time between the intervention and ED discharge, the time between the first medical contact and ED discharge and return visits within 48 hours. The primary analysis will be the difference in the amount of tolerated oral rehydration between the two groups. Based on a preliminary study of children suffering from VGE, it was estimated that the recruitment of 238 participants would provide a power of 80% to identify a difference of 15 ml between the two groups.
Expected results:
We hope that this study will demonstrate that an oral sucrose solution given at triage to children presenting with symptoms compatible with acute acute viral gastroenteritis promotes oral hydration and consequently increases the total amount of rehydration solution tolerated by children.
Conditions
- Gastroenteritis Acute
- Vomiting
Interventions
- DIETARY_SUPPLEMENT
-
sucrose
The experimental arm will receive 1.5 ml/kg of the sucrose solution at triage (once). The composition of the homemade sucrose solution used in our emergency department is 3.5 g of table sugar (sucrose) mixed with 10 ml of water. For this double-blind study, we replaced water with diluted juice (see standard arm description) to obtain a solution with the same appearance as the standard arm. With the idea of correcting ketosis, we chose to provide the same amount of sugar as we do in hypoglycemia (0.4-0.5 g/kg of dextrose) to participants in the intervention group, which represents 1.5 ml/kg of the sucrose solution containing 0.4 g of sucrose/mL for a total of 0.6 g/kg of sucrose.
- DIETARY_SUPPLEMENT
-
Standard rehydration solution
This group will receive 1.5 mL/kg of diluted juice composed of juice (apple or orange) and water in equal proportion once at triage. This solution contains 0.05 g/ml of sucrose for a total of 0.075 g/kg of sucrose (eight times less than the intervention arm).
Sponsors & Collaborators
-
Jocelyn Gravel
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 83 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-11
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
NCT01234883 ·Status: TERMINATED ·Phase: PHASE4
-
Safety, Acceptability, and Feasibility of Enterade®
NCT03782272 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement
NCT02777541 ·Status: UNKNOWN ·Phase: NA
-
Sugammadex Versus Neostigmine in Pediatric Less Than Two Years Undergoing Cardiac Catheterization
NCT04258007 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Iron Sucrose in Children
NCT00239642 ·Status: COMPLETED ·Phase: PHASE4
-
Gastric Emptying During Labor at Term: Non-inferiority Clinical Trial
NCT03280706 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders
NCT06904027 ·Status: RECRUITING
-
Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)
NCT03909165 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)
NCT03351608 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex and Neostigmine in Pediatric Patients
NCT05618236 ·Status: COMPLETED
-
Modified ORS Solution for Severely Malnourished Children
NCT01821586 ·Status: COMPLETED ·Phase: PHASE2
-
Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit
NCT05828758 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Open-label Study of the Safety and Pharmacokinetics of the TGKP
NCT06127381 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Reducing Fasting Time in Children for Sedation
NCT05757882 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT01451411 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children
NCT04347486 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Sugammadex in the Critically Ill
NCT03791801 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children
NCT03943888 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
NCT01637272 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Reversal With Neostigmine and Sugammadex in Paediatric
NCT03137290 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea
NCT02660970 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Time and Resources for Hylenex-facilitated SC Rehydration Versus ORT for Dehydrated Children in the Emergency Department (ED)
NCT01120431 ·Status: WITHDRAWN ·Phase: PHASE4
-
Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.
NCT06048614 ·Status: RECRUITING ·Phase: NA
-
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
NCT06035757 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates
NCT04566796 ·Status: UNKNOWN ·Phase: NA